Multiple sclerosis

There are 937 papers on multiple sclerosis in aging research: 122 trials and 308 observational studies in people, 41 in animals, 4 in cells, 405 reviews. The newest story, Nov 13, 2026: “Dark areas on brain scans showed disease-specific patterns”.

Disease

937 papers study it443 more mention it214 findings

MeSH

44 new papers in 30 daysSee all 1,380 papers on multiple sclerosis

“When pooled, almost half of trial participants (46.5%) had ≥1 comorbidity”
Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial PopulationsNeurology2024doi:10.1212/wnl.0000000000209135
  • Human trial122
  • Humans308
  • Animals41
  • Cells4
  • In silico33

Interventions

8

Nitrogen dioxide

no changein humans1

1 study
  1. Nitrogen dioxide showed no clear effect on multiple sclerosis in humans (0.98, 95% CI: 0.95-1.01).

    “nitrogen dioxide (NO2, 0.98, 95% CI: 0.95-1.01) were associated with MS risk”

    Review

    Association of long-term outdoor air pollution exposure with incidence of Parkinson's disease, multiple sclerosis and motor neuron diseases: a systematic review and meta-analysis

    Environment international

More on Nitrogen dioxide

Fine particulate matter

no changein humans1

1 study
  1. Fine particulate matter showed no clear effect on multiple sclerosis in humans (1.01; 0.77-1.32).

    “There was no clear evidence that PM2.5 (1.01; 0.77-1.32) or nitrogen dioxide (NO2, 0.98, 95% CI: 0.95-1.01) were associated with MS risk”

    Review

    Association of long-term outdoor air pollution exposure with incidence of Parkinson's disease, multiple sclerosis and motor neuron diseases: a systematic review and meta-analysis

    Environment international

More on Fine particulate matter

Irisin

downin mice1

1 study
  1. Irisin decreases multiple sclerosis in mice (experimental autoimmune encephalomyelitis (EAE)).

    “reduces both clinical symptoms and neuronal loss in EAE”

    Animalsexperimental autoimmune encephalomyelitis (EAE)peripheral delivery

    Exercise hormone reduces nerve cell loss in mice

    Nature metabolism

More on Irisin

Low birth weight

no changein humans1

1 study
  1. Low birth weight was not clearly linked with multiple sclerosis in humans.

    “no associations were observed for MS, PD, or migraine after full adjustment”

    Humansn = 279,842

    The relationship between low birth weight and neurological disorders: a prospective cohort study in the UK Biobank

    BMC neurology

More on Low birth weight

pTreg depletion

downin mice1

1 study
  1. pTreg depletion decreases multiple sclerosis in aged EAE mice.

    “Transiently inhibiting FoxP3 or depleting pTreg cells partially corrected Treg distribution and restored the Treg/Teff balance in the aged inflamed CNS, thereby ameliorating the disease in the aged EAE mice.”

    Animalsin aged EAE mice

    Accumulation of pTreg cells is detrimental in late-onset (aged) mouse model of multiple sclerosis

    Aging cell

More on pTreg depletion

Foxp3 inhibition

downin mice1

1 study
  1. Foxp3 inhibition decreases multiple sclerosis in aged EAE mice.

    “Transiently inhibiting FoxP3 or depleting pTreg cells partially corrected Treg distribution and restored the Treg/Teff balance in the aged inflamed CNS, thereby ameliorating the disease in the aged EAE mice.”

    Animalsin aged EAE mice

    Accumulation of pTreg cells is detrimental in late-onset (aged) mouse model of multiple sclerosis

    Aging cell

More on Foxp3 inhibition

Epigallocatechin gallate

downin reviews1

1 study
  1. Epigallocatechin gallate decreases multiple sclerosis in animal models.

    “improves the clinical severity in multiple sclerosis in animal models”

    Reviewin animal models

    Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders

    Nutrients

More on Epigallocatechin gallate

Quercetin

downin reviews1

1 study
  1. Quercetin decreases multiple sclerosis in humans or animal models.

    “quercetin has reportedly attenuated rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and systemic lupus erythematosus in humans or animal models.”

    Reviewin humans or animal models

    Potential Implications of Quercetin in Autoimmune Diseases

    Frontiers in immunology

More on Quercetin

Effects

66

Cognitive function

downin humans4

4 studies
  1. Multiple sclerosis is linked with worse cognitive function in humans (b = -0.30, p = .002).

    “Both diabetes (b = -0.30, p = .022) and MS (b = -0.30, p = .002) were independently associated with overall cognition.”

    Humans

    Comorbid diabetes and multiple sclerosis negatively affect cognitive functioning in older adults

    Multiple sclerosis and related disorders

  2. Multiple sclerosis is linked with worse cognitive function in humans (controlling for age, gender and education) (p<.01).

    “older pwMS demonstrated worse performance than people without MS (pwoMS) on tests of information processing speed, learning and delayed recall (all p<.01)”

    Humanscontrolling for age, gender and educationn = 99

    A description of processing speed, learning and memory in people with multiple sclerosis aged 55

    Multiple sclerosis and related disorders

  3. Multiple sclerosis is linked with worse cognitive function in humans (older adults with MS compared with older adults without MS) (exceeded 1⁄2 SD (i.e., Cohen's d of 0.5)).

    “older adults with MS demonstrated decreased cognitive performance that exceeded 1⁄2 SD compared with the older adults without MS.”

    Humansolder adults with MS compared with older adults without MS

    Preliminary Evidence For The Effects Of Aging And Multiple Sclerosis On Cognitive Performance: An Analysis Based On Effect Size Estimates

    Experimental aging research

  4. Multiple sclerosis impairs cognitive function in older PwMS.

    “older PwMS may present with accelerated cognitive decline”

    Reviewin older PwMS

    Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature

    Geriatrics (Basel, Switzerland)

Health-related quality of life

downin humans2

2 studies
  1. Multiple sclerosis is linked with lower health-related quality of life in humans (regardless of age).

    “HRQOL was significantly lower in participants with MS than HCs, regardless of age.”

    Humansregardless of age

    Cross-sectional, comparative study of health-related quality of life across the adult lifespan in multiple sclerosis

    The International journal of neuroscience

  2. Multiple sclerosis is linked with worse health-related quality of life in humans (multiple sclerosis).

    “The MS group had significantly lower component scores on the SF-36 and the GLTEQ than the control group.”

    Humansmultiple sclerosis

    Health-Related Quality of Life and Physical Activity in Older Adults With Multiple Sclerosis

    International journal of MS care

Frailty

upin humans1no changein silico1

2 studies
  1. Multiple sclerosis is linked with higher frailty in humans (adjusted for demographic and clinical characteristics) (0.21 ± 0.12 vs 0.11 ± 0.08).

    “Multivariable analysis identified significantly higher frailty index in pwMS (0.21 ± 0.12 vs 0.11 ± 0.08, p < 0.0001).”

    Humansadjusted for demographic and clinical characteristics

    Frailty in ageing persons with multiple sclerosis

    Multiple sclerosis (Houndmills, Basingstoke, England)

  2. Multiple sclerosis showed no clear effect on frailty in silico.

    “MS presented no causal association with fracture and frailty”

    In silicoafter excluding outlier SNPs with potential pleiotropic effects and correcting for multiple testing

    Pleiotropic Genetic Effects between Multiple Sclerosis and Musculoskeletal Traits

    medRxiv : the preprint server for health sciencesPreprint

Mean upper cervical cord area

downin humans1

1 study
  1. Multiple sclerosis is linked with lower mean upper cervical cord area in multiple sclerosis patients compared with healthy controls (p <= 0.039).

    “Patients with MS (n = 1,295, median age 42.0 years, 68% female) showed cord Z -scores below zero from age 30 years ( p ≤ 0.039)”

    Humansin multiple sclerosis patients compared with healthy controls

    Spinal cord atrophy in multiple sclerosis exceeds normal aging

    Neurology

NfL-derived age

upin humans1OR 1.44

1 study
  1. Multiple sclerosis is linked with higher NfL-derived age in humans (compared to controls) (OR = 1.44; 95% CI 1.10-1.87; p = 0.007).

    “PwMS showed a higher likelihood than controls of having a NfL-derived age above their chronological age (OR = 1.44;95%CI 1.10-1.87; p = 0.007).”

    Humanscompared to controls

    Evaluating the neurofilament light chain-derived gap between biological and chronological age in multiple sclerosis and controls

    Journal of neurology

More on NfL-derived age

Pain severity

upin humans1

1 study
  1. Multiple sclerosis is linked with higher pain severity in humans among participants who reported pain.

    “older adults with multiple sclerosis reported worse pain severity and interference”

    Humansamong participants who reported pain

    Perceived pain and its association with physical functioning in older adults with and without multiple sclerosis

    Multiple sclerosis and related disorders

Colorectal cancer screening coverage

downin humans1

1 study
  1. Multiple sclerosis is linked with lower colorectal cancer screening coverage in humans (vs matched controls) (41.2% vs 42.4%).

    “Annual CCS coverage was 41.2% in pwMS and 42.4% in controls (p < 0.001).”

    Humansvs matched controls

    Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study

    Multiple sclerosis (Houndmills, Basingstoke, England)

PIEZO2

downin human cells1

1 study
  1. Multiple sclerosis decreases PIEZO2 in human cells (multiple sclerosis optic nerve lesion areas).

    “OL-encoded PIEZO2 expression is reduced in optic nerve lesion areas from multiple sclerosis patients”

    Cellsmultiple sclerosis optic nerve lesion areasoptic nerve

    Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis

    Communications biology

More on PIEZO2

Normalized choroid plexus volume z-score

upin humans1

1 study
  1. Multiple sclerosis is linked with higher normalized choroid plexus volume z-score in humans (multiple sclerosis) (EM z-score = 0.452, p-FDR<0.001).

    “Patients with MS had significantly higher NChPV z-scores than controls (estimated mean [EM] z-score = 0.452, p-FDR<0.001)”

    Humansmultiple sclerosis

    Lifespan Modeling of Choroid Plexus Volume in Multiple Sclerosis and Its Dynamic Associations With Clinical, MRI, and HLA Susceptibility

    Neurology(R) neuroimmunology & neuroinflammation

More on Normalized choroid plexus volume z-score

Brain-PAD

upin humans1

1 study
  1. Multiple sclerosis is linked with higher brain-PAD in people with multiple sclerosis versus healthy controls (7.07 vs -0.50 years, p < 0.0001).

    “T2-FLAIR-based brain-PAD was higher in pwMS than healthy controls (7.07 vs -0.50 years, p < 0.0001).”

    Humansin people with multiple sclerosis versus healthy controls

    Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis

    Human brain mapping

More on Brain-PAD

Gait variability

upin humans1

1 study
  1. Multiple sclerosis increases gait variability in humans (P < 0.001).

    “OAMS demonstrated higher gait variability, on all measures, relative to HOA during both STW and DTW (P < 0.001).”

    Human trial

    Within-session dual-task walking practice improves gait variability in older adults with multiple sclerosis

    Gait & posture

Prospective memory

downin humans1

1 study
  1. Multiple sclerosis impairs prospective memory in multiple sclerosis (PwMS) vs controls across age groups.

    “On the TEMP total score, a two-way analysis of covariance showed a main effect of age, a main effect of the presence of MS, as well as a significant Age × Disease interaction.”

    Human trialin multiple sclerosis (PwMS) vs controls across age groupsn = 80

    Effect of multiple sclerosis and aging on prospective memory using the ecological test of prospective memory

    Neuropsychology

All 66

Upstream

3

Epstein-Barr virus DNA load

no changein humans1

1 study
  1. Epstein-Barr virus DNA load was not clearly linked with multiple sclerosis in humans (Mendelian randomization) (P = 0.52).

    “but not multiple sclerosis (P = 0.52).”

    HumansMendelian randomization

    The DNA virome varies with human genes and environments

    Nature

More on Epstein-Barr virus DNA load

Immunological age

no changein humans1

1 study
  1. Immunological age was not clearly linked with multiple sclerosis in humans.

    “we found no relation of IA to Multiple Sclerosis”

    Humans

    Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations

    bioRxiv : the preprint server for biologyPreprint

More on Immunological age

Serum urate

no changein silico1OR 1.01

1 study
  1. Serum urate showed no clear effect on multiple sclerosis in silico (OR: 1.01, 95 % CI: 0.89-1.14, P = 0.90).

    “MS (OR: 1.01, 95 % CI: 0.89-1.14, P = 0.90) risk when combined with the FinnGen consortium”

    In silico

    No causal relationship between serum urate and neurodegenerative diseases: A Mendelian randomization study

    Experimental gerontology

More on Serum urate

Associations

112

Cellular senescence

upin humans3upin reviews1

4 studies
  1. Multiple sclerosis is associated with cellular senescence in humans.

    “Single-nucleus RNA-sequencing analysis of neurons from human MS patients revealed a comparable senescence-like phenotype.”

    Humansneurons

    Cellular rejuvenation protects neurons from inflammation mediated cell death

    bioRxiv : the preprint server for biologyPreprint

  2. Cellular senescence is associated with multiple sclerosis in humans.

    “Recent work has begun to uncover an accelerated aging and senescence-like phenotype arising in patients with MS and its preclinical animal models.”

    Reviewbrain

    When the Brain Grows Old Too Soon: Aging and Senescence as a Driver of MS Progression

    The Journal of neuroscience : the official journal of the Society for Neuroscience

  3. Cellular senescence is associated with multiple sclerosis in progressive multiple sclerosis.

    “cellular senescence as a disease-related process linked to progressive forms of multiple sclerosis (MS)”

    Reviewin progressive multiple sclerosis

    Therapeutic opportunities for targeting cellular senescence in progressive multiple sclerosis

    Current opinion in pharmacology

  4. Multiple sclerosis is associated with cellular senescence.

    “we provide, for the first time, evidence of senescence in neurons and glia in multiple sclerosis, using the novel GL13 lipofuscin stain as a marker of cellular senescence.”

    Reviewnervous system

    Ageing, Cellular Senescence and Neurodegenerative Disease

    International journal of molecular sciences

More on Cellular senescence

Frailty

upin humans3downin silico1OR 0.984–15.3

4 studies
  1. Frailty is associated with multiple sclerosis in humans (OR 15.3, 99.75% CI 12.8-18.2).

    “The top five long-term conditions associated with frailty were multiple sclerosis (OR 15·3; 99·75% CI 12·8-18·2)”

    Humans

    Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants

    The Lancet. Public health

  2. Multiple sclerosis is associated with frailty in humans (multiple sclerosis) (17 % to 66 %).

    “frailty is highly prevalent in MS, with prevalences ranging from 17 % to 66 %”

    Reviewmultiple sclerosis

    Frailty in multiple sclerosis: A scoping review

    Multiple sclerosis and related disorders

  3. Multiple sclerosis lowers the risk of frailty in silico (OR = 0.984, 95% CI: 0.977-0.992).

    “negative causal association between MS (OR = 0.984, 95% CI: 0.977-0.992, p = 4.87*10^-5) and frailty”

    In silico

    Does autoimmune diseases increase the risk of frailty? A Mendelian randomization study

    Frontiers in endocrinology

  4. Multiple sclerosis raises the risk of frailty in humans (compared to age-matched individuals without MS) (up to a 15 times higher risk).

    “People with multiple sclerosis (MS) have up to a 15 times higher risk of being frail compared to age-matched individuals without MS.”

    Reviewcompared to age-matched individuals without MS

    Mental health and frailty in people with multiple sclerosis: unraveling a complex relationship

    Frontiers in psychology

Brain age gap

upin humans3

3 studies
  1. Multiple sclerosis is associated with brain age gap in humans.

    “systemic accelerated aging is identified in multiple sclerosis and dementia”

    Humans

    Topology-constrained graph transformer network for structural and functional brain organization

    Medical image analysis

  2. Brain age gap is linked with a higher risk of multiple sclerosis in humans (highest-risk group (Q4)) (6.4-fold).

    “The highest-risk group (Q4) shows a 2.8-fold increased risk of Alzheimer's disease, a 6.4-fold risk of multiple sclerosis, and a 2.4-fold higher mortality risk.”

    Humanshighest-risk group (Q4)

    Brain age gap as a predictive biomarker that links aging, lifestyle, and neuropsychiatric health

    Communications medicine

  3. Multiple sclerosis is associated with brain age gap in humans across five brain-age models (2.67 to 4.24 years across models).

    “Alzheimer's dementia and multiple sclerosis exhibited the largest BAG across all models”

    Humansacross five brain-age modelsbrain

    Analysis of Brain Age Gap across Subject Cohorts and Prediction Model Architectures

    Biomedicines

More on Brain age gap

Smoking

upin humans3

3 studies
  1. Smoking is linked with a higher risk of multiple sclerosis in humans (global burden 1990 to 2021).

    “From a global perspective, smoking-attributable deaths and disability-adjusted life years from both dementia and multiple sclerosis have risen.”

    Humansglobal burden 1990 to 2021

    Global, regional and national burden of neurodegenerative diseases attributable to smoking: A descriptive study based on the Global Burden of Disease Study 2021

    Tobacco induced diseases

  2. Smoking is associated with multiple sclerosis in humans.

    “Tobacco use increased the burden of ND such as ADOD and multiple sclerosis (MS)”

    Humans

    Global, regional, and national burden of tobacco-related neurological disorders from 1990 to 2021: Trends and future projections

    Tobacco induced diseases

  3. Smoking raises the risk of multiple sclerosis in multiple sclerosis.

    “cigarette smoking is among the most consistent modifiable environmental exposures associated with increased MS risk and worse clinical outcomes.”

    Reviewin multiple sclerosis

    Smoking accelerates immunosenescence in multiple sclerosis

    Frontiers in immunology

More on Smoking

Telomere length

upin humans3HR 3.71

3 studies
  1. Telomere length is associated with multiple sclerosis in humans.

    “although it was positively associated with multiple sclerosis.”

    Humans

    A telomere-lipid-immunity axis linking viral integration to autoimmune disease risk

    GeroScience

  2. Telomere length is linked with a higher risk of multiple sclerosis in humans (incident risk) (HR: 3.71, 95% CI 1.91-7.18, P < 0.001).

    “longer LTL was associated with a 3.71-fold increased risk of multiple sclerosis (MS) (HR: 3.71, 95% CI 1.91-7.18, P < 0.001)”

    Humansincident risk

    Association between leukocyte telomere length and neurodegenerative diseases: a prospective cohort in the UK Biobank

    Journal of neurology

  3. Telomere length is linked with a higher risk of multiple sclerosis in humans (OR 1.91, 95% CI 1.48-2.47).

    “The genetic liability to longer telomere length was associated with a higher risk of MS susceptibility (odds ratio [OR] per one-SD telomere length, 1.91; 95% confidence interval [CI], 1.48-2.47”

    Humans

    Genetically predicted telomere length and multiple sclerosis

    Multiple sclerosis and related disorders

More on Telomere length

Dementia

upin humans3HR 1.56–2.87

3 studies
  1. Multiple sclerosis is linked with a higher risk of dementia in humans (diagnosed ≥1 year after MS diagnosis) (adjusted SHR = 4.919, 95% CI: 4.329-5.743).

    “MS was associated with an almost five-fold increased risk of dementia (adjusted SHR = 4.919, 95% CI: 4.329-5.743, p < 0.001).”

    Humansdiagnosed ≥1 year after MS diagnosis

    Multiple sclerosis and the risk of dementia: a real-world, nationwide cohort study

    Frontiers in neurology

  2. Multiple sclerosis is associated with dementia in humans (Adjusted HR 1.56, 95% CI 1.39–1.76).

    “Among older veterans with MS, risk of dementia diagnosis was higher compared to matched controls even after controlling for comorbidities.”

    HumansMultiple sclerosis versus matched patients without multiple sclerosis; adjusted for potential confoundersmean follow-up 9.5 years (MS) and 10.8 years (non-MS)93.6% malesn = 4,084

    Risk of dementia in older veterans with multiple sclerosis

    Multiple sclerosis and related disorders

  3. Multiple sclerosis is associated with dementia in humans (HR 2.87, 95% CI 1.92–4.30).

    “multiple sclerosis (HR, 2.87; 95% CI, 1.92-4.30), and necrotizing vasculopathies (HR, 1.71; 95%CI, 1.03-2.85) were significantly related to higher dementia incidence.”

    Humans

    Immune-mediated diseases are associated with a higher incidence of dementia: a prospective cohort study of 375,894 individuals

    Alzheimer's research & therapy

More on Dementia

Brain age

upin humans2

2 studies
  1. Multiple sclerosis is associated with brain age in humans (multiple sclerosis).

    “MS was associated with advanced predicted brain age cross-sectionally and accelerated brain aging longitudinally in all techniques.”

    Humansmultiple sclerosis

    "Brain age" predicts disability accumulation in multiple sclerosis

    Annals of clinical and translational neurology

  2. Multiple sclerosis is associated with brain age in multiple sclerosis.

    “MRI studies consistently identify older-appearing brain structure at group level”

    Reviewin multiple sclerosis

    Biological Aging in Multiple Sclerosis: Brain–Body Relationships, Reserve, and Brain-Health Preservation—International Evidence and GCC Implications

    Preprints.orgPreprint

More on Brain age

Biological age

upin humans2

2 studies
  1. Multiple sclerosis is associated with biological age in multiple sclerosis.

    “Outcomes indicate accelerated biological aging in MS”

    Reviewin multiple sclerosis

    Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis

    Neurodegenerative disease management

  2. Multiple sclerosis is associated with biological age in humans (MS).

    “biological aging is accelerated in people with MS compared with age- and sex-matched healthy controls.”

    ReviewMS

    Biological aging in multiple sclerosis

    Multiple sclerosis (Houndmills, Basingstoke, England)

HannumAge

upin humans1upin silico1OR 1.0707–1.071

2 studies
  1. HannumAge is linked with a higher risk of multiple sclerosis in humans (OR = 1.0707, 95% CI 1.0056-1.1401, p = 0.03295).

    “Additionally, we identified that HannumAge was linked to an increased risk of Multiple Sclerosis (OR = 1.0707, 95% CI 1.0056-1.1401, p = 0.03295).”

    Humans

    The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study

    Frontiers in endocrinology

  2. HannumAge raises the risk of multiple sclerosis in silico (inverse-variance weighted Mendelian randomization) (OR = 1.071, 95%CI:1.006-1.140, p = 0.033).

    “HannumAge was associated with multiple sclerosis (OR = 1.071, 95%CI:1.006-1.140, p = 0.033, by inverse-variance weighted).”

    In silicoinverse-variance weighted Mendelian randomization

    Assessment of relationships between epigenetic age acceleration and multiple sclerosis: a bidirectional mendelian randomization study

    Epigenetics & chromatin

More on HannumAge

Falls

upin humans1upin silico1

2 studies
  1. Multiple sclerosis is associated with falls in humans during the COVID-19 pandemic (58.5% vs 21.8%, p<0.001).

    “People living with MS (pwMS) had a significantly higher frequency of falls (58.5% vs 21.8%; p< 0.001) and recurrent falls (45.3% vs 9.8%; p< 0.001) compared to non-MS participants.”

    Humansduring the COVID-19 pandemicn = 239

    Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey

    Multiple sclerosis and related disorders

  2. Multiple sclerosis is associated with falls in silico (RG=0.10, p=0.01).

    “LDSR analysis showed a moderate genetic correlation of MS with falls (RG=0.10, p=0.01)”

    In silico

    Pleiotropic Genetic Effects between Multiple Sclerosis and Musculoskeletal Traits

    medRxiv : the preprint server for health sciencesPreprint

Depression

upin humans1

1 study
  1. Multiple sclerosis is associated with depression in humans (16.45% (95% CI 12.96-20.88)).

    “Depression (16.45% [12.96-20.88], I2 = 98.3) was the most prevalent comorbidity reported, followed by hypertension (10.16% [8.61-11.98], I2 = 93.2).”

    Human trialn = 17,926

    Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

    Neurology

More on Depression

Comorbidity

upin humans1+47%

1 study
  1. Multiple sclerosis is associated with comorbidity in humans (46.5%).

    “When pooled, almost half of trial participants (46.5%) had ≥1 comorbidity”

    Human trialn = 17,926

    Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

    Neurology

All 112

Trial sponsors

Funding

40 grants since 2017

US Department of Veterans AffairsNational Institute of Neurological Disorders and Stroke$9MNational Institute of Allergy and Infectious Diseases$2.4M

Latest

Dec 2025: 37Jan 2026: 30Feb 2026: 42Mar 2026: 40Apr 2026: 23May 2026: 19Jun 2026: 26Jul 2026: 26Aug 2026: 24Sep 2026: 18Oct 2026: 30Nov 2026: 17332 papers in 12 months
medRxiv

Dark areas on brain scans showed disease-specific patterns

An observational study compared brain scans from 7,587 patients across 21 brain disorders against an age-based reference built from 34,148 healthy people.An observational study compared brain scans from 7,587 patients across 21 brain disorders against an age-based reference built from 34,148 healthy people.

Preprint: cross-sectional · 7,587 peopleBiomarkers

See all 1,380 papers on multiple sclerosis